tirzepatide compound lawsuit Eli Lilly can proceed with against telehealth seller of weight-loss drugs Lilly Statement on Mounjaro® (tirzepatide)

In particular, in both studies, liraglutide 1.8 mg/day induced a significant increase in SHBG and a decrease in free testosterone

That schedule is not arbitrary

The longer someone uses a GLP-1 receptor agonist , the higher the apparent DVT risk becomes

In January 2025, Novo Nordisk disclosed key findings from the STEP UP study , a Phase IIIb trial within the global STEP program

Key takeaways GLP-1 medications can affect birth control differently depending on the type you use

If you're storing pens at room temperature, mark your calendar or set smartphone reminders for the 21-day limit from removal from refrigeration